ADALIMUMAB DOSE REDUCTION IN RHEUMATOID ARTHRITIS, PSORIATIC ARTHROPATHY AND ANKYLOSING SPONDYLITIS PATIENTS IN SUSTAINED CLINICAL REMISSION

被引：1
|
作者：
Borras-Blasco, J. [1 ]
Gracia-Perez, A. [2 ]
Antonio Perez-Torres, A. [2 ]
Castera, D. -E. [1 ]
Abad, J. [1 ]
Rosique-Robles, D. [1 ]
机构：
[1] Hosp Sagunto, Pharm Serv, Sagunto, Spain
[2] Hosp Sagunto, Rheumatol Sect, Sagunto, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.4919
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0175
引用
收藏
页码：241 / 241
页数：1
相关论文
共 50 条
  • [31] Real-world evidence of the impact of adalimumab on work productivity and sleep measures in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
    Tektonidou, Maria G.
    Katsifis, Gkikas
    Georgountzos, Athanasios
    Theodoridou, Athina
    Koukli, Eftychia-Maria
    Kandili, Anna
    Giokic-Kakavouli, Giasna
    Karatsourakis, Theofilos-Diamantis
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2020, 12
  • [32] Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis
    Paramarta, Jacqueline E.
    De Rycke, Leen
    Heijda, Tanja F.
    Ambarus, Carmen A.
    Vos, Koen
    Dinant, Huib J.
    Tak, Paul P.
    Baeten, Dominique L.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (11) : 1793 - 1799
  • [33] Clinical remission in rheumatoid arthritis and psoriatic arthritis
    Lubrano, E.
    Mesina, F.
    Caporali, R.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2018, 36 (05) : 900 - 910
  • [34] Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
    Rossini, M.
    Viapiana, O.
    Orsolini, G.
    Fracassi, E.
    Idolazzi, L.
    Gatti, D.
    Adami, S.
    Govoni, M.
    REUMATISMO, 2014, 66 (04) : 285 - 303
  • [35] EFFICACY AND SAFETY OF ADALIMUMAB FOR THE TREATMENT OF PERIPHERAL ARTHRITIS IN SPONDYLOARTHRITIS PATIENTS WITHOUT ANKYLOSING SPONDYLITIS OR PSORIATIC ARTHRITIS
    Paramarta, J.
    De Rycke, L.
    Heijda, T.
    Ambarus, C.
    Von, K.
    Dinant, H.
    Tak, P. P.
    Baeten, D.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : 640 - 640
  • [36] Efficacy and Safety of Adalimumab for the Treatment of Peripheral Arthritis in Spondyloarthritis Patients without Ankylosing Spondylitis or Psoriatic Arthritis
    Paramarta, Jacqueline E.
    De Rycke, Leen
    Heijda, Tanja F.
    Ambarus, Carmen A.
    Vos, Koen
    Dinant, Huib J.
    Tak, Paul P.
    Baeten, Dominique L.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S235 - S235
  • [37] Duration Of Symptoms Before Diagnosis In Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis.
    Hetland, Merete Lund
    Sorensen, Jan
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S42 - S43
  • [38] Biosimilar Infliximab Treated-Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in France: Characteristics and Clinical Outcomes
    Marotte, Hubert
    Mammar, Nadir
    Fautrel, Bruno
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [39] Weight Change before and after Diagnosis in Patients with Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis
    Ogdie, Alexis
    George, Michael D.
    Gelfand, Joel
    Dubreuil, Maureen
    Love, Thorvardur
    Baker, Joshua
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [40] GOLIMUMAB UTILIZATION PATTERNS AND REFILL ADHERENCE IN PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
    Ellis, L.
    Bolge, S.
    Rice, P.
    VALUE IN HEALTH, 2014, 17 (03) : A49 - A50
12345